SlideShare uma empresa Scribd logo
1 de 51
RECENT ADVANCES IN MANAGEMENT
OF BURNS
PRESENTED BY:Dr.SHYAM SUNDER REDDY
UNIT CHIEF:Dr.N.V.N REDDY SIR
ASSOCIATE PROFESSOR:Dr. LATCHU SIR
ASSISTANT PROFESSOR:Dr.MANJUSHA MAM
Dr.DEVENDER SIR
MODERATOR:Dr.PRIYANKA
BURNS
• Definition:
A burn is an injury to the skin or other organic tissue
caused by extremes of heat or cold,
chemicals,electricity,radiation or friction.
CLASSIFICATION OF BURNS
CONT…
ASSESSMENT OF BURNS
• Rule of Nine
• - Best used for large surface areas
.Rule of Palms
-Best used for burns <10% BSA
.LUND AND BROWDER CHART.
BURN % IN ADULTS: RULE OF NINES
LUND AND BROWDER CHART
PRE HOSPITAL CARE
. Ensure rescuer safety
. Stop the burning process:Stop,Drop,Roll
• Check for other injuries.
• A standard ABC(airway,breathing,circulation) check
followed by a rapid secondary survey.
• Cool the burn wound
HOSPITAL CARE
• A:Airway control.
• B:Breathing and ventilation.
• C:Circulation.
• D:Disability-neurological status.
• E:Exposure with environmental control.
• F:Fluid resuscitation.
FLUIDS FOR RESUSCITATION
• In chidren with burns over 10% TBSA and adults with
burns over 15% TBSA,consider the need for intravenos
fluid resuscitation.
• If oral fluids are to be used,salt must be added.
• Fluids needed can be calculated from a standard
formula.
• commomly used fluids are
• 1.crystalloid:Ringer Lactate
• 2.Hypertonic saline
• 3.Human albumin
• 4.colloids resuscitation.
• Parkland Baxter Formula
• Most widely used.
• Formula:
• Ringer lactate-4ml *kg body weight*TBSA
% Burned
•1/2 that total amt.given first 8 hours and
•1/4 that total amt.given each next 8 hours.
• ASSESMENT OF ADEQUACY OF FLUID REPLACEMENT
• Urine output is the most commonly used parameter.
• U/O>0.5-1.0ml/kg/hr
• Urine osmolarity is the most accurate parameter.
• CVP 5-10cm/H2O.
• U/O>2ml/kg/hr-sign of overhydration.
OVERRESUSCITATION COMPLICATIONS
• Poor tissue perfusion
• Compartment syndrome
• Pulmonary edema
• Pleural effusion
• Electrolyte abnormalities.
EVALUATION
• Infection of wound is a major cause of death after burns.
• Source of organisms :Both endogenous and exogenous sources.
• Bacteriology: The common organisms causing infections are
pseudomonas
aeruginosa,Escherichia,klebsiella,Proteus,Enterobacter and
Providencia.Staph aureus & group A streptococcus
pyogenes.
• Anaerobic infections are rare in burns wound.
• Classification of wound infection
• Non invasive
• The infection is limited to burn eschar.
• It may lead to early separation of eschar and increased
purulent discharge from the wound
• Invasive
• Defined as presence of organisms >1,00,000/gram of
tissue of the burn area and actively invading the subjacent
unburned tissues.
• This stage is reached if the burn wound remains
unproperly treated.
FACTORS PREDISPOSING
• Host risk factors.
• Infectious agents.
• Environment .
• Cliinical features
• These are general features and local signs at the site
of wound.
• General features
• 1.fever with chills.There may be hypothermia in gram
negative invasive sepsis.
• 2.Pulse is rapid and regular.it tends to become
thready in advanced stages od sespsis.
• 3.Intolerance to glucose load presensts as diarrhoea.
• 4.Disorientation and unresponsiveness.
• 5.Hypotension,oliguria and paralytic ileus occurs in
late stage of illness.
• 6.The infection and its systemic manifestations
may lead to multiple organ failure.This is a grave
complication with high mortality.
Local signs in non invasive infections
1.Eschar separates rapidly
2.Profuse purulent discharge
3.Granulations remains pink
4.No changes are obseved in the unburnedviable
tissue
Local signs in invasive wound infection
1.Partial thickness burns gets converted into full
thickness injury
2.Focal or generalized violaceous dark brown or black
discolouration of wound.
3.Subeschar suppuration.
4.Hemorrhagic discoloration of subeschar fat
5.Rapid sloughing of burned tissue(eschar).
6.Granulation tissue becomes pale,dry and
crusted.These degenerate and form “NEOESCHAR”
7.Purplish discoloration,edema and ulceration of
unburned skin at wound margin.
8.Development of Erythema gangrenosum.
9.Vesicle formation in healing partial thickness burns.
10.Failure to take graft.
DIGNOSIS OF BURN WOUND SEPSIS
• In addition to clinical features,the investigation which
can help in the diagnosis of burn wound sepsis
include:
• 1.Wound biopsy
• 2.Surface culture
• 3.Blood culture
• 4.Leukocyte count
PREVENTION AND TREATMENT
The control of infection is carried out by following
interventions
• 1.Topical medications.
• 2.Systemic antibiotics.
• 3.Surgical management of wound.
4.Immunotherapy
5.Biological and synthetic skin substitutes
6.Nutrition
Topical medication
-topical therapy has decreased the infection rate of
wound significantly.
-to be effective should be started as early as possible
after the injury and changes are made according to
the condition of wound and bacteriologic reports.
Silver suphadiazine
- is the most commonly used topics agent in burn
wound.
- It is primarily bacteriostatic with wide spectrum of
activity.
- it decreases healing time in deep dermal
burns,prevent their conversion to full thickness and
reduces the incidence of invasive sepsis.
-Mafenide and silver nitrate have contributed
significantly in reducing sepsis in burns
-The existing invasiveness can be controlled by sub
eschar antibiotics and this technique results in early
separation of eschar.
-commonly gentamycin,tobramycin and kanamycin
are the drugs used in this modality.
SYSTEMIC ANTIBIOTICS
The use of systemic antibiotics can be either
prophylactic or therapeutic
Prophylactic
Antibiotics are used prophylactically immediately
before excision, post operatively after excision of burn
wound and at the time of skin grafting.
Therepeutic antibiotics
.The choice of antimicrobials and duration of
treatment is guided by clinical status,latest culture &
sensitivity of aorganisms colonizing the burn wound.
.Usually,broad spectrum antibiotics like
aminoglycosides and third generation cephalosporins
are used. And commonly used in combination.
.The antibiotic therapy if continued long,may lead to
emergence of resistant organisms and super infection.
Surgical management
The procedures used in the surgical manegement of
burns can be classisfied as follows:
1.Management of partial thickness burns:
(a)Tangential Excision and SSG.
(b)Tangential Excision and biological dressing.
(c)Superficial Escharectomy.
Tangential burn excision and SSG
2.Management of full thickness burns:
(a)Escharotomy.
(b)Radical excision.
(c)Sequential excision.
ESCHARATOMY
Immunotherapy
A killed vaccine of corynebacterium parvum improves
antimicrobial defences and clinical trials indicate substantial
reduction(80%) in bacteremic episodes.
Levamisole, has a number of immunologic properties.
Phagocytosis is increased along with random
migration,chemokinesis, and chemotaxis of normal neutrophils.
Fibronectin acts as a circulating non specific opsonin
Cryoprecipitate infusion has been shown to replenish serum
levels of fibronectin and improves serum opsonic activity.
.Lithium has proven useful for treatment of
granulopoietic defect in other disease styates and may
be applicable in the future.
.The use of FFP in the burn patient has resulted in
icreases in neutrophil functionalchemotactic activity.
-This lends to the use of plasma exchange and
hemodialysis in severly burned patients.
.Pyran, a synthetic anionic copolymer increases
protection against bacterial and fungal infection.
.CP-46,665 a lipoidal amine,improves phagocytosis..
Enhancement of cell mediated immunity
.Defect in CMI in the burn patient are accurate
predictors of subsequent sepsis and mortality.
.The most expeditious means of avoiding CMI
depression may be to perform early excison of burn
tissue.
.Early excision and grafting may markedely improve
lymphocyte function.
-Cyclophosphamide, an alkylating antitumour
agent,which appears to be selectively inhibit
suppresser lymphocyte proliferation when used in low
concentration may prove to be useful.
-Histamines and prostaglandins are implicated
in the stimulation of suppressor T cells,both class
inhibitors may be effective in preserving delayed
hypersensitivity responses.
-Endotoxin may activate suppressor cells,the use of
polymyxin B,which will bind and inactivate endotoxin
may prove useful.
Other drugs that have offered immunologic
improvement include
a)IL-2
b)Indomethacin
c)TP-5(Pentapeptide derived from thymopoietin)
d)Vit A
e)Vit E
immunotherapy immunomodulation
Anti bacterial vaccines
Immunoglobulins
FFP
Cryoprecipitate
Nutrition
Corynebacterium parvum
.levamisole
.lithium
.Endotoxin
.Pyran
.CP-46,665
.H2 Receptor antagonists
.Prostaglandin inhibitors
.Cyclophosphamide
.Polymyxin B
.Thymosin
.Thymopoietin
Immuno–Activeagents
Skin substitutes
1) Biologic skin substitutes
a)Human allograft
b)Amniotic membrane
c)Xenografts
2) Synthetic skin substitutes
a)Synthetic bilaminate
b)Collagen based composites
-Biobrane
-Transcyte
-integra
3)Collagen based dermal analogs
a)Dee-epithelized allograft
b)Alloderm
4)Cell culture derived
a)keratinocyte cell sprays
b)bilayer human tissue (apligraf)
c)polyglycolic or acid mesh (dermagraft)
d)cultured autologous keratinocytes
e)fibroblast seeded dermal analogs
f)epithelial seeded dermal analogs
Application of biobrane
Removal of biobrane
Transcyte
Integra Integra applied on skin
Nutrition
.High protein,high calorie and low fat diet is required
for burns patient.
.EARLY ENTERAL FEEDS throug NG Tube (TBSA
15%)
-tolerated in burn patients.
-preserve mucosal integrity.
-Reduce magnitude of hypermetabolic
response
.Parenteral when enteral is not tolerated
Sutherland formula
.Children:60 kcal/kg + 35 kcal% TBSA
.Adults:20 kcal/kg + 70 kcal % TBSA
Protein
1.5 to 2 g/kg protein/day
Future care of burn wound
(a)Enzymatic debridement:
-it will be effective in helping to differentiate the
partial and full thickness burn wound
-it should be painless with ease of appllication and
without any untoward toxic effects.
(b) Vaccines :
-jones et al developed vaccines against
pseudomonas.
-it may help in preventing septicemia due to
massive burn wound sepsis.
(B)Cultured skin:
-the biologists have cultivated cells into sheets
-the culture may start from patients own cell to avoid
immunologic problems.
-drawbacks are high cost and long time
(C)Topical oxygen:
-the susceptbility to infection increases if circulation or
oxygen delivery is decreased.
-in experiments,topical oxygen promotes healing
though thicker scar is produced.
-it needs further research to be used in extensive
burns,to prevent infection and reducing healing time.
PSSR BURNS (1).pptx

Mais conteúdo relacionado

Semelhante a PSSR BURNS (1).pptx

Odontogenic Infections
Odontogenic InfectionsOdontogenic Infections
Odontogenic InfectionsHadi Munib
 
INFLAMMATION, INFECTION, PYAEMIA, TOXEMIA,.pptx
INFLAMMATION, INFECTION, PYAEMIA, TOXEMIA,.pptxINFLAMMATION, INFECTION, PYAEMIA, TOXEMIA,.pptx
INFLAMMATION, INFECTION, PYAEMIA, TOXEMIA,.pptxvijay916906
 
Antibiotics in maxillofacial infection
Antibiotics in maxillofacial  infectionAntibiotics in maxillofacial  infection
Antibiotics in maxillofacial infectionAlka Singh
 
Management of Cancer patients
Management of Cancer patientsManagement of Cancer patients
Management of Cancer patientsHanan Shanab
 
Mucormycosis in head and neck region
Mucormycosis in head and neck regionMucormycosis in head and neck region
Mucormycosis in head and neck regionSanika Kulkarni
 
Surgical site infection
Surgical site infectionSurgical site infection
Surgical site infectionAmit Poudel
 
WOUND AND RECENT MANAGEMENT TRENDS
WOUND AND RECENT MANAGEMENT TRENDSWOUND AND RECENT MANAGEMENT TRENDS
WOUND AND RECENT MANAGEMENT TRENDSRobal Lacoul
 
Burn and Burn Rehabilitation by Dr shyam sunder sharma
Burn and Burn Rehabilitation by Dr shyam sunder sharmaBurn and Burn Rehabilitation by Dr shyam sunder sharma
Burn and Burn Rehabilitation by Dr shyam sunder sharmadrshyamsundersharma
 
Recent guidelines in antibiotics uses
Recent guidelines in antibiotics usesRecent guidelines in antibiotics uses
Recent guidelines in antibiotics usesShivshankar Badole
 
WOUND_COVER_OPTIONS_IN_BURNS_PATIENTS_ppt_[1.pptx
WOUND_COVER_OPTIONS_IN_BURNS_PATIENTS_ppt_[1.pptxWOUND_COVER_OPTIONS_IN_BURNS_PATIENTS_ppt_[1.pptx
WOUND_COVER_OPTIONS_IN_BURNS_PATIENTS_ppt_[1.pptxharshal1994
 
Integumentary System
Integumentary SystemIntegumentary System
Integumentary Systempinoy nurze
 
Surgical infections
Surgical infectionsSurgical infections
Surgical infectionsdrssp1967
 
Purulent inflammatory diseases of bones, joints and soft tissue
Purulent inflammatory diseases of bones, joints and soft tissuePurulent inflammatory diseases of bones, joints and soft tissue
Purulent inflammatory diseases of bones, joints and soft tissueMOHAMMAD NOUR AL SAEED
 
Hand Infections3.pptx
Hand Infections3.pptxHand Infections3.pptx
Hand Infections3.pptxNtambi Rogers
 

Semelhante a PSSR BURNS (1).pptx (20)

Odontogenic Infections
Odontogenic InfectionsOdontogenic Infections
Odontogenic Infections
 
INFLAMMATION, INFECTION, PYAEMIA, TOXEMIA,.pptx
INFLAMMATION, INFECTION, PYAEMIA, TOXEMIA,.pptxINFLAMMATION, INFECTION, PYAEMIA, TOXEMIA,.pptx
INFLAMMATION, INFECTION, PYAEMIA, TOXEMIA,.pptx
 
Antibiotics in maxillofacial infection
Antibiotics in maxillofacial  infectionAntibiotics in maxillofacial  infection
Antibiotics in maxillofacial infection
 
Limb Salvage in Severe Necrotizing Fascitis.pptx
Limb Salvage in Severe Necrotizing Fascitis.pptxLimb Salvage in Severe Necrotizing Fascitis.pptx
Limb Salvage in Severe Necrotizing Fascitis.pptx
 
Management of Cancer patients
Management of Cancer patientsManagement of Cancer patients
Management of Cancer patients
 
Mucormycosis in head and neck region
Mucormycosis in head and neck regionMucormycosis in head and neck region
Mucormycosis in head and neck region
 
Surgical site infection
Surgical site infectionSurgical site infection
Surgical site infection
 
WOUND AND RECENT MANAGEMENT TRENDS
WOUND AND RECENT MANAGEMENT TRENDSWOUND AND RECENT MANAGEMENT TRENDS
WOUND AND RECENT MANAGEMENT TRENDS
 
Burn and Burn Rehabilitation by Dr shyam sunder sharma
Burn and Burn Rehabilitation by Dr shyam sunder sharmaBurn and Burn Rehabilitation by Dr shyam sunder sharma
Burn and Burn Rehabilitation by Dr shyam sunder sharma
 
Surgical site infection
Surgical site infectionSurgical site infection
Surgical site infection
 
Wound infection
Wound infectionWound infection
Wound infection
 
Recent guidelines in antibiotics uses
Recent guidelines in antibiotics usesRecent guidelines in antibiotics uses
Recent guidelines in antibiotics uses
 
WOUND_COVER_OPTIONS_IN_BURNS_PATIENTS_ppt_[1.pptx
WOUND_COVER_OPTIONS_IN_BURNS_PATIENTS_ppt_[1.pptxWOUND_COVER_OPTIONS_IN_BURNS_PATIENTS_ppt_[1.pptx
WOUND_COVER_OPTIONS_IN_BURNS_PATIENTS_ppt_[1.pptx
 
Integumentary System
Integumentary SystemIntegumentary System
Integumentary System
 
Burns
BurnsBurns
Burns
 
Burn
BurnBurn
Burn
 
Burn.pptx
Burn.pptxBurn.pptx
Burn.pptx
 
Surgical infections
Surgical infectionsSurgical infections
Surgical infections
 
Purulent inflammatory diseases of bones, joints and soft tissue
Purulent inflammatory diseases of bones, joints and soft tissuePurulent inflammatory diseases of bones, joints and soft tissue
Purulent inflammatory diseases of bones, joints and soft tissue
 
Hand Infections3.pptx
Hand Infections3.pptxHand Infections3.pptx
Hand Infections3.pptx
 

Mais de shyam sunder

Clinicoradiological And Pathological Correlation Of Autopsy Study In.pptx
Clinicoradiological And Pathological Correlation Of Autopsy Study In.pptxClinicoradiological And Pathological Correlation Of Autopsy Study In.pptx
Clinicoradiological And Pathological Correlation Of Autopsy Study In.pptxshyam sunder
 
cns-antiepileptics-190304062504.pptx
cns-antiepileptics-190304062504.pptxcns-antiepileptics-190304062504.pptx
cns-antiepileptics-190304062504.pptxshyam sunder
 
meningitis FINAL.pptx
meningitis FINAL.pptxmeningitis FINAL.pptx
meningitis FINAL.pptxshyam sunder
 
meningitis FINAL 2.pptx
meningitis FINAL 2.pptxmeningitis FINAL 2.pptx
meningitis FINAL 2.pptxshyam sunder
 
Awareness-Presentation-Schools.pptx
Awareness-Presentation-Schools.pptxAwareness-Presentation-Schools.pptx
Awareness-Presentation-Schools.pptxshyam sunder
 
PAROTID SWELLING ps.pptx
PAROTID SWELLING ps.pptxPAROTID SWELLING ps.pptx
PAROTID SWELLING ps.pptxshyam sunder
 
brachial plexus final.pptx
brachial plexus final.pptxbrachial plexus final.pptx
brachial plexus final.pptxshyam sunder
 
KOTHAGUDEM-KPI.pptx
KOTHAGUDEM-KPI.pptxKOTHAGUDEM-KPI.pptx
KOTHAGUDEM-KPI.pptxshyam sunder
 
DOC-20230223-WA0019. copy.pptx
DOC-20230223-WA0019. copy.pptxDOC-20230223-WA0019. copy.pptx
DOC-20230223-WA0019. copy.pptxshyam sunder
 
Presentation (5).pptx
Presentation (5).pptxPresentation (5).pptx
Presentation (5).pptxshyam sunder
 
cavernou sinus anatomy.pptx
cavernou sinus anatomy.pptxcavernou sinus anatomy.pptx
cavernou sinus anatomy.pptxshyam sunder
 
cavernoussinus-130717084241-phpapp01.pdf
cavernoussinus-130717084241-phpapp01.pdfcavernoussinus-130717084241-phpapp01.pdf
cavernoussinus-130717084241-phpapp01.pdfshyam sunder
 
Spine_Radiography.pptx
Spine_Radiography.pptxSpine_Radiography.pptx
Spine_Radiography.pptxshyam sunder
 
1-Radiological anatomy of spine.ppt
1-Radiological anatomy of spine.ppt1-Radiological anatomy of spine.ppt
1-Radiological anatomy of spine.pptshyam sunder
 

Mais de shyam sunder (17)

Lat ven
Lat venLat ven
Lat ven
 
Clinicoradiological And Pathological Correlation Of Autopsy Study In.pptx
Clinicoradiological And Pathological Correlation Of Autopsy Study In.pptxClinicoradiological And Pathological Correlation Of Autopsy Study In.pptx
Clinicoradiological And Pathological Correlation Of Autopsy Study In.pptx
 
cns-antiepileptics-190304062504.pptx
cns-antiepileptics-190304062504.pptxcns-antiepileptics-190304062504.pptx
cns-antiepileptics-190304062504.pptx
 
Brainstemppt
BrainstempptBrainstemppt
Brainstemppt
 
meningitis FINAL.pptx
meningitis FINAL.pptxmeningitis FINAL.pptx
meningitis FINAL.pptx
 
meningitis FINAL 2.pptx
meningitis FINAL 2.pptxmeningitis FINAL 2.pptx
meningitis FINAL 2.pptx
 
Awareness-Presentation-Schools.pptx
Awareness-Presentation-Schools.pptxAwareness-Presentation-Schools.pptx
Awareness-Presentation-Schools.pptx
 
PAROTID SWELLING ps.pptx
PAROTID SWELLING ps.pptxPAROTID SWELLING ps.pptx
PAROTID SWELLING ps.pptx
 
brachial plexus final.pptx
brachial plexus final.pptxbrachial plexus final.pptx
brachial plexus final.pptx
 
KOTHAGUDEM-KPI.pptx
KOTHAGUDEM-KPI.pptxKOTHAGUDEM-KPI.pptx
KOTHAGUDEM-KPI.pptx
 
DOC-20230223-WA0019. copy.pptx
DOC-20230223-WA0019. copy.pptxDOC-20230223-WA0019. copy.pptx
DOC-20230223-WA0019. copy.pptx
 
Presentation (5).pptx
Presentation (5).pptxPresentation (5).pptx
Presentation (5).pptx
 
cavernou sinus anatomy.pptx
cavernou sinus anatomy.pptxcavernou sinus anatomy.pptx
cavernou sinus anatomy.pptx
 
cavernoussinus-130717084241-phpapp01.pdf
cavernoussinus-130717084241-phpapp01.pdfcavernoussinus-130717084241-phpapp01.pdf
cavernoussinus-130717084241-phpapp01.pdf
 
Spine_Radiography.pptx
Spine_Radiography.pptxSpine_Radiography.pptx
Spine_Radiography.pptx
 
1-Radiological anatomy of spine.ppt
1-Radiological anatomy of spine.ppt1-Radiological anatomy of spine.ppt
1-Radiological anatomy of spine.ppt
 
Renal anomalies
Renal anomaliesRenal anomalies
Renal anomalies
 

Último

Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 

Último (20)

Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 

PSSR BURNS (1).pptx

  • 1. RECENT ADVANCES IN MANAGEMENT OF BURNS PRESENTED BY:Dr.SHYAM SUNDER REDDY UNIT CHIEF:Dr.N.V.N REDDY SIR ASSOCIATE PROFESSOR:Dr. LATCHU SIR ASSISTANT PROFESSOR:Dr.MANJUSHA MAM Dr.DEVENDER SIR MODERATOR:Dr.PRIYANKA
  • 2. BURNS • Definition: A burn is an injury to the skin or other organic tissue caused by extremes of heat or cold, chemicals,electricity,radiation or friction.
  • 5. ASSESSMENT OF BURNS • Rule of Nine • - Best used for large surface areas .Rule of Palms -Best used for burns <10% BSA .LUND AND BROWDER CHART.
  • 6. BURN % IN ADULTS: RULE OF NINES
  • 8. PRE HOSPITAL CARE . Ensure rescuer safety . Stop the burning process:Stop,Drop,Roll • Check for other injuries. • A standard ABC(airway,breathing,circulation) check followed by a rapid secondary survey. • Cool the burn wound
  • 9. HOSPITAL CARE • A:Airway control. • B:Breathing and ventilation. • C:Circulation. • D:Disability-neurological status. • E:Exposure with environmental control. • F:Fluid resuscitation.
  • 10. FLUIDS FOR RESUSCITATION • In chidren with burns over 10% TBSA and adults with burns over 15% TBSA,consider the need for intravenos fluid resuscitation. • If oral fluids are to be used,salt must be added. • Fluids needed can be calculated from a standard formula. • commomly used fluids are • 1.crystalloid:Ringer Lactate • 2.Hypertonic saline • 3.Human albumin • 4.colloids resuscitation.
  • 11. • Parkland Baxter Formula • Most widely used. • Formula: • Ringer lactate-4ml *kg body weight*TBSA % Burned •1/2 that total amt.given first 8 hours and •1/4 that total amt.given each next 8 hours.
  • 12.
  • 13. • ASSESMENT OF ADEQUACY OF FLUID REPLACEMENT • Urine output is the most commonly used parameter. • U/O>0.5-1.0ml/kg/hr • Urine osmolarity is the most accurate parameter. • CVP 5-10cm/H2O. • U/O>2ml/kg/hr-sign of overhydration.
  • 14. OVERRESUSCITATION COMPLICATIONS • Poor tissue perfusion • Compartment syndrome • Pulmonary edema • Pleural effusion • Electrolyte abnormalities.
  • 15. EVALUATION • Infection of wound is a major cause of death after burns. • Source of organisms :Both endogenous and exogenous sources. • Bacteriology: The common organisms causing infections are pseudomonas aeruginosa,Escherichia,klebsiella,Proteus,Enterobacter and Providencia.Staph aureus & group A streptococcus pyogenes. • Anaerobic infections are rare in burns wound.
  • 16. • Classification of wound infection • Non invasive • The infection is limited to burn eschar. • It may lead to early separation of eschar and increased purulent discharge from the wound • Invasive • Defined as presence of organisms >1,00,000/gram of tissue of the burn area and actively invading the subjacent unburned tissues. • This stage is reached if the burn wound remains unproperly treated.
  • 17. FACTORS PREDISPOSING • Host risk factors. • Infectious agents. • Environment .
  • 18. • Cliinical features • These are general features and local signs at the site of wound. • General features • 1.fever with chills.There may be hypothermia in gram negative invasive sepsis. • 2.Pulse is rapid and regular.it tends to become thready in advanced stages od sespsis. • 3.Intolerance to glucose load presensts as diarrhoea.
  • 19. • 4.Disorientation and unresponsiveness. • 5.Hypotension,oliguria and paralytic ileus occurs in late stage of illness. • 6.The infection and its systemic manifestations may lead to multiple organ failure.This is a grave complication with high mortality.
  • 20. Local signs in non invasive infections 1.Eschar separates rapidly 2.Profuse purulent discharge 3.Granulations remains pink 4.No changes are obseved in the unburnedviable tissue
  • 21. Local signs in invasive wound infection 1.Partial thickness burns gets converted into full thickness injury 2.Focal or generalized violaceous dark brown or black discolouration of wound. 3.Subeschar suppuration. 4.Hemorrhagic discoloration of subeschar fat 5.Rapid sloughing of burned tissue(eschar).
  • 22. 6.Granulation tissue becomes pale,dry and crusted.These degenerate and form “NEOESCHAR” 7.Purplish discoloration,edema and ulceration of unburned skin at wound margin. 8.Development of Erythema gangrenosum. 9.Vesicle formation in healing partial thickness burns. 10.Failure to take graft.
  • 23. DIGNOSIS OF BURN WOUND SEPSIS • In addition to clinical features,the investigation which can help in the diagnosis of burn wound sepsis include: • 1.Wound biopsy • 2.Surface culture • 3.Blood culture • 4.Leukocyte count
  • 24. PREVENTION AND TREATMENT The control of infection is carried out by following interventions • 1.Topical medications. • 2.Systemic antibiotics. • 3.Surgical management of wound.
  • 25. 4.Immunotherapy 5.Biological and synthetic skin substitutes 6.Nutrition
  • 26. Topical medication -topical therapy has decreased the infection rate of wound significantly. -to be effective should be started as early as possible after the injury and changes are made according to the condition of wound and bacteriologic reports.
  • 27.
  • 28. Silver suphadiazine - is the most commonly used topics agent in burn wound. - It is primarily bacteriostatic with wide spectrum of activity. - it decreases healing time in deep dermal burns,prevent their conversion to full thickness and reduces the incidence of invasive sepsis.
  • 29. -Mafenide and silver nitrate have contributed significantly in reducing sepsis in burns -The existing invasiveness can be controlled by sub eschar antibiotics and this technique results in early separation of eschar. -commonly gentamycin,tobramycin and kanamycin are the drugs used in this modality.
  • 30. SYSTEMIC ANTIBIOTICS The use of systemic antibiotics can be either prophylactic or therapeutic Prophylactic Antibiotics are used prophylactically immediately before excision, post operatively after excision of burn wound and at the time of skin grafting.
  • 31. Therepeutic antibiotics .The choice of antimicrobials and duration of treatment is guided by clinical status,latest culture & sensitivity of aorganisms colonizing the burn wound. .Usually,broad spectrum antibiotics like aminoglycosides and third generation cephalosporins are used. And commonly used in combination. .The antibiotic therapy if continued long,may lead to emergence of resistant organisms and super infection.
  • 32. Surgical management The procedures used in the surgical manegement of burns can be classisfied as follows: 1.Management of partial thickness burns: (a)Tangential Excision and SSG. (b)Tangential Excision and biological dressing. (c)Superficial Escharectomy.
  • 34. 2.Management of full thickness burns: (a)Escharotomy. (b)Radical excision. (c)Sequential excision.
  • 36. Immunotherapy A killed vaccine of corynebacterium parvum improves antimicrobial defences and clinical trials indicate substantial reduction(80%) in bacteremic episodes. Levamisole, has a number of immunologic properties. Phagocytosis is increased along with random migration,chemokinesis, and chemotaxis of normal neutrophils. Fibronectin acts as a circulating non specific opsonin Cryoprecipitate infusion has been shown to replenish serum levels of fibronectin and improves serum opsonic activity.
  • 37. .Lithium has proven useful for treatment of granulopoietic defect in other disease styates and may be applicable in the future. .The use of FFP in the burn patient has resulted in icreases in neutrophil functionalchemotactic activity. -This lends to the use of plasma exchange and hemodialysis in severly burned patients. .Pyran, a synthetic anionic copolymer increases protection against bacterial and fungal infection. .CP-46,665 a lipoidal amine,improves phagocytosis..
  • 38. Enhancement of cell mediated immunity .Defect in CMI in the burn patient are accurate predictors of subsequent sepsis and mortality. .The most expeditious means of avoiding CMI depression may be to perform early excison of burn tissue. .Early excision and grafting may markedely improve lymphocyte function.
  • 39. -Cyclophosphamide, an alkylating antitumour agent,which appears to be selectively inhibit suppresser lymphocyte proliferation when used in low concentration may prove to be useful. -Histamines and prostaglandins are implicated in the stimulation of suppressor T cells,both class inhibitors may be effective in preserving delayed hypersensitivity responses. -Endotoxin may activate suppressor cells,the use of polymyxin B,which will bind and inactivate endotoxin may prove useful.
  • 40. Other drugs that have offered immunologic improvement include a)IL-2 b)Indomethacin c)TP-5(Pentapeptide derived from thymopoietin) d)Vit A e)Vit E
  • 41. immunotherapy immunomodulation Anti bacterial vaccines Immunoglobulins FFP Cryoprecipitate Nutrition Corynebacterium parvum .levamisole .lithium .Endotoxin .Pyran .CP-46,665 .H2 Receptor antagonists .Prostaglandin inhibitors .Cyclophosphamide .Polymyxin B .Thymosin .Thymopoietin Immuno–Activeagents
  • 42. Skin substitutes 1) Biologic skin substitutes a)Human allograft b)Amniotic membrane c)Xenografts 2) Synthetic skin substitutes a)Synthetic bilaminate b)Collagen based composites -Biobrane -Transcyte -integra
  • 43. 3)Collagen based dermal analogs a)Dee-epithelized allograft b)Alloderm 4)Cell culture derived a)keratinocyte cell sprays b)bilayer human tissue (apligraf) c)polyglycolic or acid mesh (dermagraft) d)cultured autologous keratinocytes e)fibroblast seeded dermal analogs f)epithelial seeded dermal analogs
  • 47. Nutrition .High protein,high calorie and low fat diet is required for burns patient. .EARLY ENTERAL FEEDS throug NG Tube (TBSA 15%) -tolerated in burn patients. -preserve mucosal integrity. -Reduce magnitude of hypermetabolic response .Parenteral when enteral is not tolerated
  • 48. Sutherland formula .Children:60 kcal/kg + 35 kcal% TBSA .Adults:20 kcal/kg + 70 kcal % TBSA Protein 1.5 to 2 g/kg protein/day
  • 49. Future care of burn wound (a)Enzymatic debridement: -it will be effective in helping to differentiate the partial and full thickness burn wound -it should be painless with ease of appllication and without any untoward toxic effects. (b) Vaccines : -jones et al developed vaccines against pseudomonas. -it may help in preventing septicemia due to massive burn wound sepsis.
  • 50. (B)Cultured skin: -the biologists have cultivated cells into sheets -the culture may start from patients own cell to avoid immunologic problems. -drawbacks are high cost and long time (C)Topical oxygen: -the susceptbility to infection increases if circulation or oxygen delivery is decreased. -in experiments,topical oxygen promotes healing though thicker scar is produced. -it needs further research to be used in extensive burns,to prevent infection and reducing healing time.